文献速递胰腺与胆道疾病消化内镜

EPISOD研究:长期结局

The EPISOD study: long-term outcomes.
PubMed 文献 · Gastrointest Endosc · 2017-04-25

EPISOD研究将胆囊切除术后疼痛且无或很少胆道梗阻客观证据的患者随机分至括约肌切开术或假干预,1年时积极治疗无获益;本次报告随访至5年(中位58个月)的结局,结果显示括约肌切开术不优于假干预(部分标准下更差),作者认为ERCP不再推荐。

要点

  • 随访至5年,括约肌切开术与假干预在主要疼痛标准上成功率相似。
  • 按PGIC标准,括约肌切开术组成功率低于假干预组。
  • 作者结论:这些患者症状真实且常严重,ERCP不再推荐,需进一步研究有效管理。

核心结论

  • 这些数据证实初步报告,内镜下括约肌切开术在这些患者中不优于假干预(且按某些标准更差),ERCP不再推荐。
  • 患者症状真实且常严重,需进一步研究以建立有效管理。

研究设计与样本

  • EPISOD研究为随机对照试验,将胆囊切除术后疼痛且无或很少胆道梗阻客观证据的患者随机分至括约肌切开术或假干预。
  • 完成1年随访且仍对治疗分配设盲的103例患者入组,每6个月电话随访,中位随访58个月(范围17-71个月)。
  • 最终访视时按2项标准评估成功:RAPID疼痛评分<6,以及PGIC问卷为明显或非常明显改善(均无重复干预且未使用麻醉药)。

主要发现

  • 按RAPID标准,括约肌切开术组成功率26/65(40%),假干预组16/38(42%)。
  • 按PGIC标准,括约肌切开术组16/43(37%),假干预组16/22(73%)。
  • 整个研究期间共75例患者接受积极治疗,其RAPID标准成功率为31/41(原文此处写作31(41%),按上下文应为31/75(41%)),从未接受积极治疗者成功率为16(62%)(原文未写明分母)。

临床怎么用

  • 原文结论指出ERCP不再推荐用于此类患者。
  • 原文结论指出需进一步研究以建立有效管理。

局限性

  • 原文结论指出需进一步研究以建立有效管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The EPISOD (Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction) study randomized patients with post-cholecystectomy pain, and little or no objective evidence for biliary obstruction, to sphincterotomy or sham intervention. Results at 1 year showed no benefit for the active treatment. We now report the outcomes at up to 5 years. METHODS: One hundred three patients completing 1 year, and still blinded to treatment allocation, were enrolled and followed by phone every 6 months for a median of 58 months (range, 17-71 months). Their success was assessed at the final visit by 2 criteria: (1) a low pain score (Recurrent Abdominal Pain and Disability instrument [RAPID] <6) and (2) much or very much improved on the Patients' Global Impression of Change (PGIC) questionnaire (both with no repeat intervention and not taking narcotics). RESULTS: By the RAPID criteria, success rates for the patients in the sphincterotomy and sham arms were similar: 26/65 (40%) versus 16/38 (42%), respectively. However, by the PGIC criteria, actively treated patients fared worse: 16/43 (37%) versus 16/22 (73%). A total of 75 patients underwent active treatment during the entire study. Their success rate by the RAPID criteria was 31 (41%) compared with 16 (62%) who had no active treatment at any time. CONCLUSIONS: These data confirm our initial report that endoscopic sphincterotomy is no better than sham intervention in these patients (and, by some criteria, worse), and that ERCP can no longer be recommended. The patients have genuine and often severe symptoms, and further research is needed to establish effective management. (Clinical trial registration number: 00688662 05/3/2008.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Cotton PB, Pauls Q, Keith J, et al. The EPISOD study: long-term outcomes. Gastrointest Endosc. 2017. PMID: 28455162. doi:10.1016/j.gie.2017.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。